Insulin Resistance in Non-alcoholic Fatty Liver Disease

NCT00252499 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

13

Enrollment

FED

Sponsor class

Stopped Protocol drug change required new clinicaltrails.gov entry

Conditions

Fatty Liver
Insulin Resistance

Interventions

DRUG: rosiglitazone
DRUG: fenofibrate
DRUG: placebo for rosiglitazone
DRUG: placebo for fenofibrate

Sponsor

US Department of Veterans Affairs